pyruvic acid has been researched along with Coronary Disease in 17 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pojar, M | 1 |
| Mand'ák, J | 1 |
| Cibícek, N | 1 |
| Lonský, V | 1 |
| Dominik, J | 1 |
| Palicka, V | 1 |
| Kubícek, J | 1 |
| Kahles, H | 1 |
| Hellige, G | 1 |
| Hunnemann, DH | 1 |
| Junggeburth, J | 1 |
| Kochsiek, K | 1 |
| Furkalo, NK | 1 |
| Rishko, NV | 1 |
| Fabián, J | 1 |
| Brodan, V | 1 |
| Spácil, J | 1 |
| Andĕl, M | 1 |
| Cavaliere, F | 1 |
| Meo, F | 1 |
| Scapigliati, A | 1 |
| Sciarra, M | 1 |
| Schiavello, R | 1 |
| Fralix, TA | 1 |
| Steenbergen, C | 1 |
| London, RE | 1 |
| Murphy, E | 1 |
| van der Meer, P | 1 |
| Huizer, T | 1 |
| de Jong, JW | 1 |
| Cavallini, L | 1 |
| Valente, M | 1 |
| Rigobello, MP | 1 |
| Renstrom, B | 2 |
| Nellis, SH | 2 |
| Liedtke, AJ | 2 |
| Mallet, RT | 2 |
| Hartman, DA | 2 |
| Bünger, R | 2 |
| Hladovec, J | 1 |
| Laustiola, K | 1 |
| Snow, TR | 1 |
| Sethna, DH | 1 |
| Moffitt, EA | 1 |
| Lampson, WG | 1 |
| Kramer, JH | 1 |
| Schaffer, SW | 1 |
1 review available for pyruvic acid and Coronary Disease
| Article | Year |
|---|---|
An appreciation of the coronary circulation.
Topics: Blood Pressure; Collateral Circulation; Coronary Circulation; Coronary Disease; Coronary Vessels; Di | 1986 |
1 trial available for pyruvic acid and Coronary Disease
| Article | Year |
|---|---|
Peripheral tissue metabolism during off-pump versus on-pump coronary artery bypass graft surgery: the microdialysis study.
Topics: Aged; Anastomosis, Surgical; Biomarkers; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Ar | 2008 |
15 other studies available for pyruvic acid and Coronary Disease
| Article | Year |
|---|---|
Different effects of interventions suppressing free fatty acid metabolism on myocardial ischemia.
Topics: Animals; Coronary Disease; Dichloroacetic Acid; Dogs; Fatty Acids, Nonesterified; Glucose; Hemodynam | 1984 |
[Oxygen and hemodynamic provisions for measured physical exertion in ischemic heart disease patients with intact and atherosclerotic coronary arteries].
Topics: Adult; Coronary Disease; Exercise Test; Hemodynamics; Humans; Lactates; Lactic Acid; Middle Aged; My | 1984 |
Importance of investigation of myocardial metabolites in diagnosis and evaluation of treatment of ischaemic heart disease.
Topics: Adult; Angina Pectoris; Cardiac Catheterization; Coronary Circulation; Coronary Disease; Female; Hum | 1984 |
Red blood cell energy metabolism during cardiopulmonary bypass.
Topics: Adenine Nucleotides; Aged; Body Temperature; Cardiopulmonary Bypass; Chromatography, High Pressure L | 1999 |
Metabolic substrates can alter postischemic recovery in preconditioned ischemic heart.
Topics: Animals; Calcium; Coronary Disease; Egtazic Acid; Energy Metabolism; Glucose; Hydrogen-Ion Concentra | 1992 |
Effects of inosine and adenine on nucleotide levels in the post-ischemic rat heart, perfused with and without pyruvate.
Topics: Adenine; Adenine Nucleotides; Animals; Coronary Disease; In Vitro Techniques; Inosine; Myocardium; N | 1990 |
The protective action of pyruvate on recovery of ischemic rat heart: comparison with other oxidizable substrates.
Topics: Acetates; Animals; Coronary Disease; Energy Metabolism; Glucose; Heart; Insulin; Lactates; Lactic Ac | 1990 |
Metabolic oxidation of pyruvate and lactate during early myocardial reperfusion.
Topics: Animals; Coronary Disease; Fatty Acids; Heart; Lactates; Lactic Acid; Myocardial Reperfusion; Myocar | 1990 |
Glucose requirement for postischemic recovery of perfused working heart.
Topics: Animals; Blood Pressure; Coronary Disease; Cytosol; Dichloroacetic Acid; Energy Metabolism; Glucose; | 1990 |
Mechanisms of substrate preference for oxidative metabolism during early myocardial reperfusion.
Topics: Acetyl Coenzyme A; Acetylcarnitine; Animals; Coronary Disease; Fatty Acids; Glycine; Myocardial Repe | 1990 |
Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure.
Topics: Acetates; Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Cytosol; Energy Metabol | 1989 |
Protective effect of oxygen-derived free radical scavengers on the endothelium in vivo.
Topics: alpha-Tocopherol; Animals; Anticoagulants; Ascorbic Acid; Aspirin; Coronary Disease; Endothelium; Fe | 1986 |
Cyclic GMP affects redox state and improves energy charge of ischaemic Langendorff-perfused rat heart.
Topics: Animals; Coronary Disease; Cyclic GMP; Energy Metabolism; Glucose; In Vitro Techniques; Lactates; La | 1985 |
A study of the effects of substrates on intracellular pH in toad ventricular strips.
Topics: Animals; Body Fluids; Bufo marinus; Carbon Dioxide; Coronary Disease; Glucose; Heart Ventricles; Hyd | 1986 |
Effect of tolbutamide on myocardial energy metabolism of the ischemic heart.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Energy Metabolism; Glucose; | 1985 |